Salesforce (CRM) Stock Forecast & Price Target

$343.65 +7.42 (+2.21%)

(As of 12/20/2024 05:45 PM ET)

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 41 Analyst Ratings

Sell
0

Hold
8

Buy
33

Based on 41 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 8 have given a hold rating, 29 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$378.86
10.25% Upside

According to the 41 analysts' twelve-month price targets for Salesforce, the average price target is $378.86. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted upside of 10.25% from the current price of $343.65.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	4 Strong Buy rating(s)	4 Strong Buy rating(s)	3 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	29 Buy rating(s)	27 Buy rating(s)	25 Buy rating(s)	26 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	12 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$378.86	$329.11	$306.00	$259.61
Forecasted Upside	10.25% Upside	-2.10% Downside	14.69% Upside	-2.53% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.90	2.68	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	10.25% Upside	264.23% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/18/2024	Macquarie 1 of 5 stars	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$370.00 ➝ $370.00	+5.50%
12/18/2024	JMP Securities 2 of 5 stars		Reiterated Rating	Market Outperform ➝ Market Outperform	$450.00 ➝ $450.00	+27.15%
12/18/2024	Wedbush 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$425.00 ➝ $425.00	+21.08%
12/18/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$405.00 ➝ $405.00	+15.38%
12/18/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$375.00 ➝ $375.00	+6.83%
12/13/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ader Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$440.00	+22.84%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
12/4/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$340.00 ➝ $360.00	-2.16%
12/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$340.00 ➝ $380.00	+3.28%
12/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$400.00 ➝ $425.00	+15.51%
12/4/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$300.00 ➝ $420.00	+16.53%
12/4/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$368.00 ➝ $390.00	+7.93%
12/4/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$425.00 ➝ $440.00	+22.47%
12/4/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$315.00 ➝ $415.00	+14.17%
12/4/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$360.00 ➝ $400.00	+8.54%
12/4/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$385.00 ➝ $415.00	+25.09%
12/4/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral
12/4/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$385.00 ➝ $425.00	+28.10%
12/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$380.00 ➝ $400.00	+20.57%
12/4/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $425.00	+28.10%
12/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$415.00 ➝ $425.00	+28.10%
12/4/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$340.00 ➝ $430.00	+29.61%
12/4/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$400.00 ➝ $440.00	+32.62%
12/4/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $440.00	+32.62%
12/4/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$330.00 ➝ $405.00	+22.07%
12/3/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$250.00 ➝ $300.00	-9.32%
11/22/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$275.00 ➝ $360.00	+5.26%
11/21/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$290.00 ➝ $340.00	+0.01%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
11/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$275.00 ➝ $330.00	-4.35%
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$234.00 ➝ $236.00	-8.87%
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$345.00 ➝ $300.00	+10.25%
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself.
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%
6/1/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
6/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
3/2/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$140.00 ➝ $200.00	+19.51%
2/21/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$160.00 ➝ $170.00	+2.92%
1/20/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:02 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce, Inc. has shown strong revenue growth, reporting $9.44 billion for the latest quarter, exceeding analyst expectations of $9.35 billion. This indicates robust demand for its services.
The stock price recently increased to $354.85, reflecting a 1.7% rise, which may suggest positive market sentiment and potential for further appreciation.
Salesforce, Inc. maintains a healthy market capitalization of approximately $339.59 billion, indicating its strong position in the market and ability to invest in growth opportunities.
The company has a solid return on equity of 12.34%, which measures how effectively it uses equity investments to generate profits, making it an attractive option for investors seeking efficient management.
Institutional investors own 80.43% of Salesforce, Inc.'s stock, which often indicates confidence in the company's future performance and stability.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Salesforce, Inc. reported earnings per share (EPS) of $2.41, which missed analysts' consensus estimate of $2.44 by $0.03. This shortfall may raise concerns about the company's ability to meet future earnings expectations.
The company's price-to-earnings (P/E) ratio stands at 59.09, which is relatively high and may suggest that the stock is overvalued compared to its earnings, potentially limiting upside for new investors.
Despite recent revenue growth, the net margin of 15.96% indicates that a significant portion of revenue is consumed by expenses, which could affect profitability in the long run.
Salesforce, Inc. has a beta of 1.30, suggesting that its stock price is more volatile than the market. This could lead to higher risk for investors, especially in uncertain market conditions.
The company has a debt-to-equity ratio of 0.14, which is low, but any increase in debt levels could impact financial stability and investor confidence.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $378.86, with a high forecast of $450.00 and a low forecast of $236.00.
: 41 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 8 hold ratings, 29 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 10.25% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 5 upgrades and 1 downgrade by analysts.
: Salesforce has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Canaccord Genuity Group, Cfra, Citigroup, DA Davidson, Erste Group Bank, Guggenheim, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., KeyCorp, Loop Capital, Macquarie, Morgan Stanley, Needham & Company LLC, Northland Capmk, Northland Securities, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Scotiabank, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.90 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

>> Register for the Workshop Now

This page (NYSE:CRM) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target